Device Trial Radar · NCT04775316
Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
Last checked: Nov 19, 2026Latest source record: Dec 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
47
Actual
Start
Sep 1, 2021
Primary completion
Nov 28, 2022
Study completion Nov 30, 2022
Sponsor
- Lead sponsor
- BSN Medical GmbHNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 1, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Although, a huge number of acute wounds is treated successfully every year, Health Care Professionals (HCPs) are facing more and more problems when treating skin damages or surgical incisions: The number of patients with fragile and/or sensitive skin is highly increasing. Such patients are having a skin integrity issue, meaning the skin is vulnerable to injury, often damaged, or unable to heal. The investigational medical devices (IMDs) of the planned clinical evaluation, Leukomed® T skin sensitive and Leukomed® T plus skin sensitive have been developed for treatment of acute wounds on patients with fragile or sensitive skin to provide a reliable but skin-friendly fixation and wound care option. The primary purpose of this clinical study is the evaluation of clinical performance to stay in place up to seven days and the safety of both dressings. Further, data on wearing comfort, product handling, pain during removal and quality of life are considered as secondary outcomes. The products will be used as part of routine wound care within the scope of their intended purpose without any additional invasive or burdensome examination.
Conditions
- Wounds and Injuries
- Skin Diseases
Interventions
Leukomed T / Tplus skin sensitive treatmentDevice
Application of sterile wound dressing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adhered dressing area after wearTime frame: 7 days after dressing application
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Practice Degenhardt
Bremen, Germany
Klinikum Dortmund
Dortmund, Germany
orthoGroup
Hamburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.